The 4 μL Sample Size is a Breakthrough
Doing more allergy tests with less sample benefits patients and labs. It seems like a little thing, but for pediatric patients, it’s really a big thing.
A NOVEOS™ System can run
10x more tests with the same
sample current systems use
Allergy profile typically has 10 - 35 tests per patient
Current Allergy instruments use 40 - 50 µL of sample per specific IgE (sIgE) test
NOVEOS sIgE uses only 4 µL of serum per test
Reflex component allergen testing will exacerbate sample shortages (Quantity Not Sufficient, QNS)
Less sample per test improves the experience of patients and permits follow-up testing with fewer re-draws!
Benefits of avoiding
Quantity Not Sufficient
Improving the patient experience while increasing management and testing efficiency
Errors occur with 2 – 10% of samples in allergy labs, and it’s more frequent in pediatric-focused labs.
QNS incidents cause an incomplete patient report, resulting in an incomplete picture for the clinician.
Reduces the need for test prioritization by clinicians and laboratorians
Reduces the need for additional office visits which cause lost productivity
Reduces trauma for the patient and parent of a child of having another blood draw
Reduce the potential loss of revenue for the laboratory
“We try to perform all the requested tests while avoiding
the trauma of another venipuncture.”
Lab, UK (1)
1. Data on File. Pain Points Market Research, May 2019.